Famotidine Injection 20 mg — Class II drug recall D-0293-2015
Terminated recall by Baxter Healthcare Corp., reported 2014-12-17, distributed nationwide. Presence of Particulate Matter: Baxter Healthcare Corporation has received a complaint reporting the presence
| Recall number | D-0293-2015 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Baxter Healthcare Corp., Deerfield, IL, United States |
| Recall initiated | 2014-04-24 |
| Classified | 2014-12-10 |
| Reported by FDA | 2014-12-17 |
| Terminated | 2015-06-16 |
| Distributed | Nationwide (US) |
| Quantity | 19,152 containers |
| Reason classes | specification failure |
| NDC | 00338-5197, 00338-5197-41 |
| Lot numbers | NC082768 |
| Expiration dates | 2014-12-23 |
Product
Famotidine Injection 20 mg, Rx Only, GALAXY Single Dose Container, Code 2G3424, Sterile Nonpyrogenic, 50 mL Iso-osmotic, Baxter Healthcare Corporation, Deerfield, IL 60015, USA, NDC 0338-5197-41.
Reason for recall
Presence of Particulate Matter: Baxter Healthcare Corporation has received a complaint reporting the presence of particulate matter identified as plastic/rubber in famotidine Injection premixed containers.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0293-2015. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.